HRS-6213
HRS-6213-101
Phase 2 small_molecule active
Quick answer
HRS-6213 for Patients With Solid Tumors is a Phase 2 program (small_molecule) at Jian Li with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jian Li
- Indication
- Patients With Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active